A Quality of Life Study in Patients With Migraines
The purpose of this study is to compare depressive characteristics in migraine patients to those observed in patients with epilepsy in a previous study, and determine whether those symptoms are unique to patients with epilepsy.
|Study Design:||Observational Model: Case-Only
Time Perspective: Prospective
|Official Title:||Dysphoric-like Disorder of Epilepsy, Is It Unique?|
- Dysphoric-like depressive characteristics in patient with epilepsy [ Time Frame: N/A (cross-sectional study) ] [ Designated as safety issue: No ]
|Study Start Date:||January 2006|
|Study Completion Date:||April 2013|
|Primary Completion Date:||June 2009 (Final data collection date for primary outcome measure)|
A form of depression known as dysphoric-like disorder is common in people with epilepsy, which may significantly affect the quality of life in these people, as shown in a previous study. However, it is unclear if this depressive disorder is unique to patients with epilepsy. In order to assess whether these symptoms are unique and idiosyncratic to the epilepsy population, in this multi-center study, these dysphoric depressive features will be contrasted to those seen in patients with other neurologic or psychiatric conditions. Migraine is selected as one of the comparison disorders because it shares with epilepsy characteristics of being a recurrent episodic central nervous system disorder, and our site will only enroll patients with migraine headaches.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00298805
|United States, New York|
|North Shore Long Island Jewish Health System|
|Great Neck, New York, United States, 11021|
|Principal Investigator:||Andres M Kanner, MD||Rush University Medical Center|